NEWS 4: Focus of worldwide Chromosome 18 research is in San Antonio
April 22, 2019
For people with Chromosome 18 abnormalities, the prognosis used to be a life spent in a near vegetative state. Watch the full story at NEWS 4
April 22, 2019
For people with Chromosome 18 abnormalities, the prognosis used to be a life spent in a near vegetative state. Watch the full story at NEWS 4
October 24, 2018
Omegaven is a lifesaving fish oil treatment for babies with gastrointestinal complications.
September 20, 2018
In budget hearings Sept. 13, the San Antonio City Council approved $751,000 for a two-year pilot program to reduce asthma hospitalizations in high-risk children. The effort’s principal investigator, Mandie Svatek, M.D., associate professor of pediatrics at UT Health San Antonio, said the program is a holistic approach to lowering the city’s childhood asthma burden. “In […]
August 2, 2017
Panel will determine guidelines for more than 50 of the most common syndromes that can develop into pediatric cancer.
February 16, 2017
Prolacta Bioscience®, the pioneer in human milk-based neonatal nutritional products, announced today that the first patient has been enrolled in a clinical study to evaluate the effect of a specially fortified exclusive human milk diet (EHMD)1 to improve growth in infants who have undergone surgery for a serious heart defect known as single ventricle cardiac […]
January 11, 2017
The Cancer Therapy & Research Center (CTRC) of UT Health San Antonio is uniting today, Jan. 11, with all the other National Cancer Institute (NCI)-designated cancer centers in the U.S. in issuing a joint statement urging parents to have their children immunized against human papillomavirus (HPV) and encouraging physicians to recommend it.